144 related articles for article (PubMed ID: 18066572)
1. The expression of somatostatin receptors 3, 4 and 5 in laryngeal pathology.
Condon LT; Stafford ND; Bedford KJ; MacDonald AW; Atkin SL
Eur Arch Otorhinolaryngol; 2008 Jul; 265 Suppl 1():S63-7. PubMed ID: 18066572
[TBL] [Abstract][Full Text] [Related]
2. The expression of somatostatin receptors 1 and 2 in benign, pre-malignant and malignant laryngeal lesions.
Stafford ND; Condon LT; Rogers MJ; MacDonald AW; Atkin SL
Clin Otolaryngol Allied Sci; 2003 Aug; 28(4):314-9. PubMed ID: 12871244
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology.
Kumar U; Grigorakis SI; Watt HL; Sasi R; Snell L; Watson P; Chaudhari S
Breast Cancer Res Treat; 2005 Jul; 92(2):175-86. PubMed ID: 15986128
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of retinoic acid receptor beta (RARbeta) and the AP-1 transcription factor in normal, premalignant and malignant human laryngeal tissues.
Karamouzis MV; Sotiropoulou-Bonikou G; Vandoros G; Varakis I; Papavassiliou AG
Eur J Cancer; 2004 Mar; 40(5):761-73. PubMed ID: 15010078
[TBL] [Abstract][Full Text] [Related]
5. Altered MUC1 and MUC2 glycoprotein expression in laryngeal cancer.
Jeannon JP; Stafford FW; Soames JV; Wilson JA
Otolaryngol Head Neck Surg; 2001 Feb; 124(2):199-202. PubMed ID: 11226957
[TBL] [Abstract][Full Text] [Related]
6. Colocalization of somatostatin receptor subtypes (SSTR1-5) with somatostatin, NADPH-diaphorase (NADPH-d), and tyrosine hydroxylase in the rat hypothalamus.
Kumar U
J Comp Neurol; 2007 Sep; 504(2):185-205. PubMed ID: 17626271
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical localization of somatostatin receptor subtypes in benign and malignant adrenal tumours.
Unger N; Serdiuk I; Sheu SY; Walz MK; Schulz S; Saeger W; Schmid KW; Mann K; Petersenn S
Clin Endocrinol (Oxf); 2008 Jun; 68(6):850-7. PubMed ID: 18031328
[TBL] [Abstract][Full Text] [Related]
8. [Significance of ceramide from precancerous lesion to carcinoma of larynx].
Yuan YS; Chi FL; Wang SY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Apr; 40(4):287-90. PubMed ID: 16008264
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin receptor subtype 5 (SSTR5) mRNA expression is related to histopathological features of cell proliferation in insulinomas.
de Sá SV; Corrêa-Giannella ML; Machado MC; de Souza JJ; Pereira MA; Patzina RA; Siqueira SA; Machado MC; Giannella-Neto D
Endocr Relat Cancer; 2006 Mar; 13(1):69-78. PubMed ID: 16601280
[TBL] [Abstract][Full Text] [Related]
10. Prolonged somatostatin therapy may cause down-regulation of SSTR-like GPCRs on Schistosoma mansoni.
Chatterjee S; Op De Beeck J; Rao AV; Desai DV; Vrolix G; Rylant F; Panis T; Bernat A; Van Bergen J; Peeters D; Van Marck E
J Vector Borne Dis; 2007 Sep; 44(3):164-80. PubMed ID: 17896619
[TBL] [Abstract][Full Text] [Related]
11. Significance of ceramide and DNA ploidy in laryngeal carcinogenesis.
Yuan Y; Chi F; Wang S; Wang Z
ORL J Otorhinolaryngol Relat Spec; 2007; 69(5):283-8. PubMed ID: 17565231
[TBL] [Abstract][Full Text] [Related]
12. Effects of selective somatostatin analogs and cortistatin on cell viability in cultured human non-functioning pituitary adenomas.
Padova H; Rubinfeld H; Hadani M; Cohen ZR; Nass D; Taylor JE; Culler MD; Shimon I
Mol Cell Endocrinol; 2008 May; 286(1-2):214-8. PubMed ID: 18276067
[TBL] [Abstract][Full Text] [Related]
13. Involvement of somatostatin receptor subtypes in membrane ion channel modification by somatostatin in pituitary somatotropes.
Yang SK; Chen C
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1221-7. PubMed ID: 17892506
[TBL] [Abstract][Full Text] [Related]
14. [Magnesium content of laryngeal precancerous conditions and laryngeal cancers].
Szmeja Z; Kończewska H
HNO; 1986 Feb; 34(2):85-7. PubMed ID: 3957730
[TBL] [Abstract][Full Text] [Related]
15. The immunohistochemical localisation of somatostatin receptors 1, 2, 3, and 5 in acoustic neuromas.
Stafford ND; Condon LT; Rogers MJ; Helboe L; Crooks DA; Atkin SL
J Clin Pathol; 2004 Feb; 57(2):168-71. PubMed ID: 14747443
[TBL] [Abstract][Full Text] [Related]
16. [DNA content in laryngeal keratosis, laryngeal cancer and normal laryngeal epithelium].
Zhi T
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1989; 24(4):236-8, 255. PubMed ID: 2486078
[TBL] [Abstract][Full Text] [Related]
17. Impact of EGFR immunoexpression on STAT3 activation and association with proinflammatory/regulatory cytokine pattern in laryngeal squamous cell carcinoma.
Starska K; Brys M; Forma E; Glowacka E; Lewy-Trenda I; Stasikowska O; Krajewska WM; Lukomski M
Oncol Rep; 2009 Feb; 21(2):539-48. PubMed ID: 19148533
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells.
Watt HL; Kharmate GD; Kumar U
Cell Signal; 2009 Mar; 21(3):428-39. PubMed ID: 19070659
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of somatostatin receptor subtypes in hepatocellular carcinomas.
Bläker M; Schmitz M; Gocht A; Burghardt S; Schulz M; Bröring DC; Pace A; Greten H; De Weerth A
J Hepatol; 2004 Jul; 41(1):112-8. PubMed ID: 15246216
[TBL] [Abstract][Full Text] [Related]
20. The expression of somatostatin receptors in the hippocampus of pilocarpine-induced rat epilepsy model.
Kwak SE; Kim JE; Choi HC; Song HK; Kim YI; Jo SM; Kang TC
Neuropeptides; 2008; 42(5-6):569-83. PubMed ID: 18951627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
